Kevin Sayer's holdings in DexCom, Inc., have seen significant fluctuations over the years. In 2019, his assets peaked at $44.14 million and reached an impressive $64.75 million by July 2020, showcasing the company's dynamic growth. However, the value of his...

Kevin Sayer's holdings in DexCom, Inc., have seen significant fluctuations over the years. In 2019, his assets peaked at $44.14 million and reached an impressive $64.75 million by July 2020, showcasing the company's dynamic growth. However, the value of his holdings has varied since then. By October 2023, they were around $27.62 million. Throughout this period, Sayer’s ownership remained a crucial indicator of his investment in the company’s future, often mirroring the company's overall market performance. This alignment not only motivates Sayer to succeed but also aligns well with shareholder interests, as evidenced by the increased focus on DexCom's strategic goals and performance metrics, particularly in the growing diabetes care market.